Neutralising antibodies to interferon beta in multiple sclerosis: analytical comparison between two different cytopathic assays

被引：0
|
作者：
Orpez, T.
Oliver, B.
Lopez-Gomez, C.
Mayorga, C.
Fernandez-Sanchez, V. E.
Alonso, A.
Luque, G.
Fernandez, O.
机构：
[1] Fdn IMABIS, Malaga, Spain
[2] Inst Neurosci Clin, Malaga, Spain
来源：
MULTIPLE SCLEROSIS | 2007年 / 13卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：S60 / S61
页数：2
相关论文
共 50 条
  • [41] Measurement of antibodies to interferon beta in patients with multiple sclerosis
    Pachner, AR
    ARCHIVES OF NEUROLOGY, 2001, 58 (08) : 1299 - 1300
  • [42] Effect of interferonβ and the development of neutralising antibodies, on reactivation of latent EBV, in patients with multiple sclerosis
    Farrell, Rachel
    Antony, Dinu
    Clark, Duncan
    Garson, Jeremy
    Miller, David H.
    Giovannoni, Gavin
    MULTIPLE SCLEROSIS, 2008, 14 : S229 - S229
  • [43] Pharmacodynamics of interferon-β in relapsing-remitting multiple sclerosis with and without neutralising antibodies
    Scagnolari, G
    Duda, P
    Alberelli, A
    Lavolpe, V
    Bagnato, F
    Girardi, E
    Trojano, M
    Kappos, L
    Antonelli, G
    MULTIPLE SCLEROSIS, 2004, 10 (7032): : S255 - S255
  • [44] Binding and Neutralising Antibodies in Relapsing-remitting Multiple Sclerosis Patients Treated with a Biosimilar Interferon Beta-1a (CinnoVex®)
    Sh, Nafissi
    Shahkarami, M. Amir
    Lam, R.
    Oger, J.
    MULTIPLE SCLEROSIS, 2010, 16 (02): : 273 - 273
  • [45] Differential utilisation of IgG subclasses in multiple sclerosis patients with binding vs. neutralising anti-interferon beta antibodies
    Menge, T.
    von Geldern, G.
    Cepak, S.
    Hochgesand, S.
    Hartung, H. -P.
    Hemmer, B.
    MULTIPLE SCLEROSIS, 2007, 13 : S62 - S62
  • [46] Socio-Economic Aspects of Testing for Neutralising Antibodies in Multiple Sclerosis Patients on Interferon beta Treatment: A Cost of Illness Study
    Deisenhammer, Florian
    Brennig, Christine
    Baltic, Dejan
    Walter, Evelyn
    NEUROLOGY, 2011, 76 (09) : A597 - A597
  • [47] Serial immunoprecipitation assays for interferon -: (IFN)-β antibodies in multiple sclerosis patients
    Lampasona, V
    Rio, J
    Franciotta, D
    Furlan, R
    Avolio, C
    Fazio, R
    Lavolpe, V
    Vincent, A
    Comi, G
    Trojano, M
    Montalban, X
    Martino, G
    EUROPEAN CYTOKINE NETWORK, 2003, 14 (03) : 154 - 157
  • [48] In-vivo response to interferon-α is preserved in multiple sclerosis patients with neutralising antibodies against interferon-β
    Magyari, M.
    Sondergaard, H. Bach
    Sellebjerg, F.
    Sorensen, P. Soelberg
    MULTIPLE SCLEROSIS JOURNAL, 2012, 18 : 202 - 202
  • [49] Significance of serum neutralising antibodies to Avonex' (IFN beta-1a) in multiple sclerosis
    Rudick, RA
    Jones, W
    Alam, J
    Simonian, N
    Campion, M
    Jacobs, L
    Herndon, R
    Richert, J
    Salazar, A
    Cookfair, D
    Simon, J
    Coats, M
    Goodkin, D
    Mass, M
    NEUROLOGY, 1997, 48 (03) : 5003 - 5003
  • [50] A weighted genetic risk score to predict neutralising antibodies to interferon-β in multiple sclerosis patients
    Hemmer, B.
    Igl, W.
    Buck, D.
    Muehlau, M.
    Schwenke, S.
    Mueller-Myhsok, B.
    Sandbrink, R.
    Pohl, C.
    MULTIPLE SCLEROSIS JOURNAL, 2012, 18 : 361 - 361
12345